New AbbVie hepatitis C combination cures 93%-97% with genotype 3

Sofosbuvir-velpatasvir successful in hep C regardless of genotype
November 19, 2015
The FDA Just Approved One Cancer-Killing Virus. Expect More
November 19, 2015
Show all

New AbbVie hepatitis C combination cures 93%-97% with genotype 3

Comments are closed.